- Home
- CMC vs BRKR Comparison
CMC vs BRKR Comparison
Compare CMC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMC | BRKR |
|---|---|---|
| Founded | 1915 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 7.0B |
| IPO Year | 1987 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CMC | BRKR |
|---|---|---|
| Price | $70.60 | $47.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $66.91 | $49.42 |
| AVG Volume (30 Days) | 1.1M | ★ 2.2M |
| Earning Date | 01-08-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.02% | 0.41% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $7,798,480,000.00 | $3,438,900,000.00 |
| Revenue This Year | $12.43 | $3.55 |
| Revenue Next Year | $6.71 | $1.49 |
| P/E Ratio | $95.23 | ★ N/A |
| Revenue Growth | N/A | ★ 6.10 |
| 52 Week Low | $37.92 | $28.53 |
| 52 Week High | $71.99 | $64.64 |
Technical Indicators
Market Signals| Indicator | CMC | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 67.60 | 60.47 |
| Support Level | $68.48 | $44.11 |
| Resistance Level | $71.02 | $49.15 |
| Average True Range (ATR) | 1.67 | 1.95 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 83.29 | 77.00 |
Price Performance
Historical ComparisonAbout CMC Commercial Metals Company
Commercial Metals Co operates steel mills, steel fabrication plants, and metal recycling facilities in the United States and manufactures rebar and structural steel, which are key product categories for the nonresidential construction sector. The Company has three operating and reportable segments: North America Steel Group, Europe Steel Group and Emerging Businesses Group.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.